FDA Investigator Steven B Hertz
Steven B Hertz has conducted inspections on 6 sites in 4 countries as of 13 Nov 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
13 Nov 2018
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland,
United States of America,
France,
Germany
FDA Investigators that have inspected at least one site in common with Steven B Hertz:
Alicia M Mozzachio,
Anita Narula, PhD,
Anita R Michael,
Anthony A Charity,
Arie C Menachem,
Arsen Karapetyan,
Bruce H Mccullough,
Carla A Norris,
CDR Donald Ertel,
Christian D Lynch (CDL),
Clotia Cabbey Mensah,
Dawn M Braswell,
Dell S Moller,
Donna Mwilliams Hill, PhD,
Farhana Khan,
Gale E Ryan,
Gilbert J Heidenblut,
Jeremy W Rotton,
Joan A Loreng,
Joshua S Hunt,
Karen E D'orazio,
Karen Takahashi,
Kenneth E Felkley,
Kevin A Gonzalez,
Kristen D Evans,
Laura Fontan, MS,
Laurie Nelson,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
LT Tamara J Henderson,
Lydia S Chan,
Marcus F Yambot,
Marianela Aponte Cruz,
Marion Michaelis,
Matthew A Spataro,
Matthew B Casale,
Meisha R Sampson,
Meisha Waters,
Meyer J Slobotsky,
Mra Davism,
Nalini D Lebzelter,
Nicole K Trudel,
Niketa Patel,
Omotunde O Osunsanmi,
Prabhu P Raju,
Rakhi B Shah,
Ramon E Martinez,
Roger F Zabinski,
Rosanna M Goodrich,
Rosanna M Vaccaro,
Russell J Glapion,
Simone E Pitts,
Stephen R Souza,
Steven D Kehoe,
Steven Fong, MS, PhD,
Susan M Jackson,
Susan O Oladeji,
Susan T Hadman,
Unnee Ranjan,
Veronica Fuentes, MS,
Vipulchandra N Dholakia,
Wayne E Seifert,
Yumi J Hiramine,
Zachary L Miller
Steven B Hertz's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2010 | FDA 483 | Nostrum Laboratories, Inc. - Form 483, 2010-07-16 |
February, 2016 | FDA 483 | G. Pohl-Boskamp GmbH & Co. KG - Form 483, 2016-02-11 |
April, 2015 | FDA 483 | Sanofi Winthrop Industrie - Form 483, 2015-04-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more